SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2192889

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 2192889

Arterial Filter Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

PUBLISHED:
PAGES: 194 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 6050
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The arterial filter market reached USD 795 million in 2025 and is projected to grow at a CAGR of 7% from 2026 to 2035. The market is expected to cross USD 1.56 billion valuation by 2035. Cardiac surgery and extracorporeal support programs require filtration components suited to established circuits and clinical protocols. Materials, blood-contact characteristics, priming volume, and compatibility influence selection, with suppliers increasingly addressing specialized adult, pediatric, and critical-care requirements around a continuing base of routine perfusion consumable demand.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$795 Million
Forecast Value$1.56 Billion
CAGR7%

Expansion of extracorporeal membrane oxygenation programs supports recurring purchases of compatible single-use components. Established replacement protocols make filters part of ongoing consumption rather than an occasional capital purchase. Cardiovascular disease also sustains the surgical patient pool, while expanding cardiac capacity in developing healthcare systems creates additional filtration requirements alongside surgery, perfusion training, and intensive care. Surface treatments provide another driver by addressing platelet activation and inflammatory response during extracorporeal circulation. Phosphorylcholine and PMEA coatings support product differentiation where clinical teams prioritize blood-contact performance. These developments connect procedure demand with a shift toward specialized configurations, allowing suppliers to compete through circuit performance and protocol fit alongside availability and price.

Based on application, cardiopulmonary bypass generated USD 676 million in 2025. Coronary bypass, valve procedures, congenital repairs, and other open-heart operations rely on established extracorporeal circulation workflows. This creates a broad procedural foundation for arterial filter consumption. Suppliers benefit from familiar clinical protocols and continuing requirements for compatible components. Faster-growing applications change the overall mix, while routine bypass procedures maintain an established purchasing base. The segment's commercial importance therefore follows from its embedded role in cardiac surgery, where perfusion teams select components as part of a coordinated circuit and value consistent performance within operating practices already used across recurring surgical activity.

Polypropylene filters are projected to generate USD 832 million by 2035. Their relevance in standard adult bypass reflects familiar processing properties, supply arrangements, and clinical use. Manufacturers and hospital teams understand the material within established product and circuit configurations. This supports recurring demand across ordinary procedures rather than dependence on a narrow specialist application. Suppliers compete through product consistency and fit with accepted perfusion workflows. The segment therefore retains a broad role as more advanced materials and coatings develop elsewhere, with the choice of filter construction influenced by routine procedural requirements and the continuity of the clinical systems in which the component will be used.

The North America arterial filter market is projected to reach USD 656 million by 2035. Established cardiac surgery infrastructure combines with broad extracorporeal membrane oxygenation capability and adherence to single-use protocols. Adoption of premium materials and coordinated perfusion purchasing support demand beyond changes in procedure numbers alone. Large hospital networks and familiar perfusion practices favor suppliers capable of sustaining regulatory, clinical, and service support. Product consistency remains relevant as hospitals select components within established circuits. The regional opportunity consequently connects recurring consumption with advanced product adoption, while purchasing teams consider the technical and institutional support needed to maintain dependable perfusion programs across demanding cardiac and critical-care environments.

LivaNova held a 13% global market revenue share in 2025. Its integrated perfusion portfolio enables arterial filters to be supplied alongside heart-lung machines, oxygenators, and related bypass components. Hospitals seeking a coordinated circuit platform provide an important customer base for this approach. Clinical familiarity across disposable products and capital systems reinforces its position within established accounts. The company competes through portfolio integration rather than filter supply alone. This reflects a wider competitive environment in which qualification, material differentiation, regulatory capability, and relationships with perfusion teams influence selection, particularly where institutions value coordinated component support and continuity within a familiar extracorporeal circulation platform.

Some of the major players in this market are GETINGE, Medtronic, Pall Corporation, TERUMO, NIPRO, EUROSETS, Beijing MEDOS AT Biotechnology, SENKO Medical Instrument, Braile Biomedica, Gen World Medical Devices, and Lifeline Systems. Their positions include integrated perfusion portfolios, specialized filtration and materials expertise, regional circuit components, and value-oriented distribution. Local qualification, application-specific configurations, technical support, and dependable supply influence their relevance across clinical programs with different infrastructure, purchasing priorities, and expectations for coordination with established cardiac surgery and extracorporeal support systems.

Product Code: 14015

Table of Contents

Chapter 1. Research Methodology

  • 1.1 Research approach
  • 1.2 Quality Commitments
    • 1.2.1 GMI AI policy & data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research Trail & Confidence Scoring
    • 1.3.1 Research Trail Components
    • 1.3.2 Scoring Components
  • 1.4 Data Collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Filter material trends
    • 2.2.2 Priming volume trends
    • 2.2.3 Age group trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
    • 2.2.6 Regional trends
  • 2.3 TAM analysis, 2027-2035
  • 2.4 CXO perspectives: strategic imperatives

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Cost structure
    • 3.1.4 Value addition at each stage
    • 3.1.5 Factors affecting the value chain
    • 3.1.6 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cardiovascular diseases
      • 3.2.1.2 Growth in cardiopulmonary bypass procedures
      • 3.2.1.3 Technological advancements in filter design
      • 3.2.1.4 Rising geriatric population
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of cardiac surgeries and devices
      • 3.2.2.2 Risk of complications from filters
    • 3.2.3 Market opportunities
      • 3.2.3.1 Development of next-gen arterial filters
      • 3.2.3.2 Growth in pediatric and neonatal cardiac surgery
  • 3.3 Growth potential analysis
  • 3.4 Pricing Analysis (Driven by Primary Research)
    • 3.4.1 Historical Price Trend Analysis
    • 3.4.2 Pricing Strategy by Player Type (Premium / Value / Cost-plus)
  • 3.5 Regulatory landscape
    • 3.5.1 North America
    • 3.5.2 Europe
    • 3.5.3 Asia-Pacific
    • 3.5.4 Latin America
    • 3.5.5 Middle East and Africa
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Trade Data Analysis (Based on Paid Database)
    • 3.8.1 Import/Export Volume & Value Trends
    • 3.8.2 Key Trade Corridors & Tariff Impact
  • 3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
    • 3.9.1 AI-Driven Disruption of Existing Business Models
    • 3.9.2 GenAI Use Cases & Adoption Roadmap by Segment
    • 3.9.3 Risks, Limitations & Regulatory Considerations
  • 3.10 Patent / IP Landscape
  • 3.11 Medical Infrastructure Landscape
  • 3.12 Epidemiology / Disease Burden

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By Region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia-Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East and Africa
    • 4.2.2 Market Concentration Analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Key developments
    • 4.5.1 Mergers & acquisitions
    • 4.5.2 Partnerships & collaborations
    • 4.5.3 New product launches
    • 4.5.4 Expansion plans and funding
  • 4.6 Company tier benchmarking
    • 4.6.1 Tier classification criteria & qualifying thresholds
    • 4.6.2 Tier positioning matrix by revenue, geography & innovation

Chapter 5. Market Estimates and Forecast, By Filter Material, 2022-2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Polypropylene
  • 5.3 Polyethylene
  • 5.4 Polyvinyl chloride (PVC)
  • 5.5 Other filter materials

Chapter 6. Market Estimates and Forecast, By Priming Volume, 2022-2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Less than 100 mL
  • 6.3 100-200 mL
  • 6.4 More than 200 mL

Chapter 7. Market Estimates and Forecast, By Age Group, 2022-2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Adult
  • 7.3 Neonatal/Pediatric

Chapter 8. Market Estimates and Forecast, By Application, 2022-2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 Cardiopulmonary bypass (CPB)
  • 8.3 Extracorporeal membrane oxygenation (ECMO)
  • 8.4 Other applications

Chapter 9. Market Estimates and Forecast, By End Use, 2022-2035 ($ Mn)

  • 9.1 Key trends
  • 9.2 Hospitals
  • 9.3 Ambulatory surgical centers
  • 9.4 Other end use

Chapter 10. Market Estimates and Forecast, By Region, 2022-2035 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
    • 10.3.7 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
    • 10.4.6 Rest of Asia-Pacific
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
    • 10.5.4 Rest of Latin America
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE
    • 10.6.4 Rest of Middle East and Africa

Chapter 11. Company Profiles

  • 11.1 Global Player
    • 11.1.1 GETINGE
    • 11.1.2 LivaNova
    • 11.1.3 Medtronic
    • 11.1.4 Pall Corporation
    • 11.1.5 TERUMO
  • 11.2 Regional Player
    • 11.2.1 NIPRO
    • 11.2.2 EUROSETS
    • 11.2.3 Beijing MEDOS AT Biotechnology
    • 11.2.4 SENKO Medical Instrument
    • 11.2.5 Braile Biomedica
  • 11.3 Emerging Player
    • 11.3.1 Gen World Medical Devices
    • 11.3.2 Lifeline Systems
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!